Hostname: page-component-77c89778f8-m8s7h Total loading time: 0 Render date: 2024-07-17T12:29:42.160Z Has data issue: false hasContentIssue false

The Effects of Cyclosporin-A on Human Vascular Smooth Muscle Cells Apoptosis

Published online by Cambridge University Press:  02 July 2020

M. Kinjo
Affiliation:
Cardiovascular Molecular Research, Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, 21201
J. S. McLaughlin
Affiliation:
Cardiovascular Molecular Research, Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, 21201
C. Wei.
Affiliation:
Cardiovascular Molecular Research, Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, 21201
Get access

Extract

Cyclosporine-A is the one of the most effective immunosuppressant drug in organ transplantation. However, cyclosporine-A has a potent cytotoxic effect. Cellular apoptosis is being suggested may contribute to the cyclosporine A-mediated cytotoxic action. To date, regarding the effects of cyclosporine-A on apoptosis and apoptosis-related genes expression in vascular smooth muscle cells remain unclear. Therefore, the current study was designed to investigate the actions of cyclosporine-A on apoptosis and p53 expression in human vascular smooth muscle cells.

Human saphenous vein was obtained from coronary artery bypass surgery (n=5). After saphenous vein removed, the tissue was minced and incubated in the special tissue culture system for 24 hours in the absence or presence of cyclosporine-A (10-6M). To detect the DNA fragmentation, in situ terminal deoxymucleotidyl transferase dUTP nick end labeling (TUNEL) was performed. The p53 level in human vascular smooth muscle cells was determined by immunohistochemical staining (IHCS). An average of 1000 nuclei was analyzed for both TUNEL and p53 EHCS studies.

Type
Apoptosis
Copyright
Copyright © Microscopy Society of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References:

1.Soares, M.P., et al. Nat. Med. (1998) 4, 10731077.CrossRefGoogle Scholar
2.Vriens, P.W., et al. J Thorac Cardiovasc Surg (1998) 116, 844853.CrossRefGoogle Scholar
3.Jurado, F., et al. Histol Histopathol (1999) 14, 10331043.Google Scholar
4.Morgan, D.C., et al. Circulation (1999) 100, 12361241.CrossRefGoogle Scholar
5. This research was supported in part by grants from the N1H (HL03174 & HL61299, C. Wei), AHAMD, NKF and University of Maryland School of Medicine.Google Scholar